Assessment of tumoral heterogeneity in NSCLC treated with Bevacizumab: a prospective study

Connie Yip, Nunzia Tacelli, Martine Remy-Jardin, Paul Bassett, Gary Cook, David Landau, Vicky Goh

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Article number	e19124
Journal	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Volume	32
Issue number	15
Publication status	Published - 2014

Cite this

@article{20d8bc6774934afc9c16efcfc069ad67,

title = "Assessment of tumoral heterogeneity in NSCLC treated with Bevacizumab: a prospective study",

author = "Connie Yip and Nunzia Tacelli and Martine Remy-Jardin and Paul Bassett and Gary Cook and David Landau and Vicky Goh",

year = "2014",

language = "English",

volume = "32",

journal = "Journal of clinical oncology : official journal of the American Society of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "15",

}

TY - JOUR

T1 - Assessment of tumoral heterogeneity in NSCLC treated with Bevacizumab

T2 - a prospective study

AU - Yip, Connie

AU - Tacelli, Nunzia

AU - Remy-Jardin, Martine

AU - Bassett, Paul

AU - Cook, Gary

AU - Landau, David

AU - Goh, Vicky

PY - 2014

Y1 - 2014

M3 - Meeting abstract

SN - 0732-183X

VL - 32

JO - Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JF - Journal of clinical oncology : official journal of the American Society of Clinical Oncology

IS - 15

M1 - e19124

ER -